Join the Eye Conditions group to help and get support from people like you.
Eye Conditions News (Page 5)
Related terms: Eye Disorders
Worried About Cataracts? Here's What You Need to Know
WEDNESDAY, May 31, 2023 – Cataracts are the leading cause of blindness around the world, but surgery can restore vision. “Unlike many of the other major eye diseases, such as glaucoma or d...
Tainted Dry Eye Drops Cause Another Death
MONDAY, May 22, 2023 – Cases of vision loss and deaths are mounting in an investigation into eye drops contaminated with a rare strain of the drug-resistant bacteria, Pseudomonas aeruginosa. In all,...
Bespoke, Code-Free AI Model Beneficial for Retinal Images
MONDAY, May 22, 2023 – Bespoke and code-free deep learning (CFDL) models can discriminate healthy retinal images from those with features of pre-plus or plus disease, indicating retinopathy of...
Incidence of Eye Injuries Linked to Nonpowder Toy Guns Increasing
WEDNESDAY, May 17, 2023 – The incidence of eye injuries associated with nonpowder guns seems to be increasing among children, and the mean age of patients with foam projectile blaster-associated...
Secondhand Smoke Exposure Linked to Myopia in Children
THURSDAY, May 18, 2023 – Secondhand smoke (SHS) exposure is associated with greater myopic refraction, longer axial length, and increased odds of developing moderate and high myopia, according to a...
Cleveland Case Suggests Tainted Eye Drops Were Harming Vision Months Before CDC Alert
FRIDAY, May 12, 2023 – Months before U.S. health officials warned that tainted eye drops were causing vision loss and even death, a Cleveland woman lost the sight in her eye in a case that puzzled...
AI Algorithms Trained on Fundus Photographs Infer Self-Reported Race
FRIDAY, May 12, 2023 – Artificial intelligence (AI) algorithms trained on fundus photographs infer the self-reported race (SRR) of infants, regardless of whether the images contain color, according...
FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of Geographic Atrophy, a Leading Cause of Blindness
WALTHAM, Mass., Feb. 17, 2023 (GLOBE NEWSWIRE) – Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the U.S. Food and...
FDA Approves Upneeq (oxymetazoline hydrochloride ophthalmic solution) for Acquired Blepharoptosis (Droopy Eyelid) in Adults
BRIDGEWATER, N.J, July 09, 2020 (GLOBE NEWSWIRE) – Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that the U....
FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 3, 2018-- Ocular Therapeutix™, Inc. a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for d...
FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative...
FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative...
FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE) September 14, 2018 --Sun Pharmaceutical Industries Ltd. and Sun Pharma Advanced Research Company Ltd. (SPARC) today announced U.S. Food and Drug...
FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis
August 22, 2018 – The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the...
Icon Bioscience Receives FDA Approval for Dexycu (dexamethasone intraocular suspension) for Treating Inflammation Associated With Cataract Surgery
Newark, CA (February 12, 2018) – Icon Bioscience, Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care th...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Glaucoma, Eye Dryness / Redness, Macular Degeneration, Cataract